Literature DB >> 9607631

Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.

J H Harmey1, E Dimitriadis, E Kay, H P Redmond, D Bouchier-Hayes.   

Abstract

BACKGROUND: Breast tumors contain high numbers of infiltrating macrophages. The role and function of these cells within the tumor remain unclear, but a number of studies have found an association between poor prognosis and macrophage content in human breast cancer. Both hypoxia and TGFbeta-1 have been shown to regulate VEGF in other cell types. We hypothesized that breast tumor-associated macrophages produce VEGF and that macrophage production of this factor is regulated by both hypoxia and TGFbeta-1.
METHODS: Paraffin-embedded breast tumor sections were stained immunohistochemically with anti-VEGF, anti-CD68, and anti-cytokeratin. Monocytes were matured for 3 days in 20% autologous plasma and activated with 1000 U/mL interferon-gamma for 24 hours. Supernatants were assayed for VEGF protein by ELISA. Total RNA was isolated from cells and reverse transcribed to cDNA, which was used as a template in PCR reactions for VEGF and beta-actin.
RESULTS: Both tumor cells and tumor macrophages produce VEGF in human breast tumors. Hypoxia increases VEGF protein and mRNA levels in monocyte-derived macrophages, whereas TGFbeta-1 increases VEGF protein but not mRNA under hypoxic growth conditions.
CONCLUSIONS: Breast tumor-associated macrophages may contribute to the angiogenic activity of human breast tumors by producing VEGF. Macrophage production of VEGF is upregulated by hypoxia and TGFbeta-1, both of which occur in the tumor environment. Macrophage production of VEGF is regulated at both the mRNA and protein levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607631     DOI: 10.1007/bf02303785

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  46 in total

Review 1.  Tumor-associated macrophages in breast cancer.

Authors:  Russell D Leek; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 2.  Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis.

Authors:  Yuichi Oike; Kunio Yasunaga; Toshio Suda
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 3.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

Review 4.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

Review 5.  Stromal cells and integrins: conforming to the needs of the tumor microenvironment.

Authors:  Aimee Alphonso; Suresh K Alahari
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

6.  Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.

Authors:  S Cascinu; F Graziano; V Catalano; M P Staccioli; S Barni; P Giordani; M C Rossi; A M Baldelli; P Muretto; A Valenti; G Catalano
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).

Authors:  Chenghai Li; Bin Liu; Zonghan Dai; Yunxia Tao
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

8.  Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.

Authors:  Nadja Osterberg; Napoleone Ferrara; Jean Vacher; Simone Gaedicke; Gabriele Niedermann; Astrid Weyerbrock; Soroush Doostkam; Hans-Eckart Schaefer; Karl H Plate; Marcia Regina Machein
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

9.  Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.

Authors:  David P Kodack; Euiheon Chung; Hiroshi Yamashita; Joao Incio; Annique M M J Duyverman; Youngchul Song; Christian T Farrar; Yuhui Huang; Eleanor Ager; Walid Kamoun; Shom Goel; Matija Snuderl; Alisha Lussiez; Lotte Hiddingh; Sidra Mahmood; Bakhos A Tannous; April F Eichler; Dai Fukumura; Jeffrey A Engelman; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

10.  A three species model to simulate application of Hyperbaric Oxygen Therapy to chronic wounds.

Authors:  Jennifer A Flegg; Donald L S McElwain; Helen M Byrne; Ian W Turner
Journal:  PLoS Comput Biol       Date:  2009-07-31       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.